Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Nontaxable or Nondeductible items

Nontaxable or Nondeductible items at other companies

John Wiley & Sons, Inc. logo
John Wiley & Sons, Inc.WLYB
$870.5K
DJT
Trump Media & Technology GroupDJT
$1.61M-89.9%
EAT
Brinker InternationalEAT
$1.93M+108%
NovaGold Resources logo
NovaGold ResourcesNG
$3.2M+480%
Rumble, Inc. logo
Rumble, Inc.RUM
$579.21K+274%
APO
Apogee EnterprisesAPOG
$221.25K

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.94B+1,017%
Enterprise value$5.89B+1,158%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpense.

The source filing: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026.

Filed
Mar 12, 2026, 4:03 PM EDT
Fiscal year
FY2025
Accession
0001213900-26-026929
Line itemYear Ended December 31, 2025 / AmountYear Ended December 31, 2025 / PercentPeriod from February 6, 2024 (inception) to December 31, 2024 / AmountPeriod from February 6, 2024 (inception) to December 31, 2024 / Percent
Tax benefit derived by applying the federal statutory rate to loss before income taxes$(22,141)(21.00$(17,582)(21.00
Nontaxable or nondeductible items540.05760.09
Credits
Research and development credits(2,109)(2.00)(2,840)(3.39)
Other9490.90(731)(0.87)
Worldwide changes in unrecognized tax benefits(91)(0.09)0.00
Change in the valuation allowance23,33822.1421,07725.17
Income tax (benefit) expense0.00%0.00%

Item 8. Financial Statements and Supplementary

FAQ

What is Oruka Therapeutics, Inc.'s nontaxable or nondeductible items?
Oruka Therapeutics, Inc. (ORKA) reported nontaxable or nondeductible items of $13.5K in Q4 2025.
How has Oruka Therapeutics, Inc.'s nontaxable or nondeductible items changed year-over-year?
Oruka Therapeutics, Inc.'s nontaxable or nondeductible items decreased by 82.2% year-over-year, from $76K to $13.5K.
What does nontaxable or nondeductible items mean?
The portion of expenses incurred by the company that are not tax-deductible under current tax regulations. These expenses increase the company's effective tax rate because they cannot be used to offset taxable income. Monitoring this helps investors understand the gap between accounting profit and taxable income.

Ask your AI about Oruka Therapeutics, Inc.'s nontaxable or nondeductible items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude